跳至主要内容
临床试验/EUCTR2009-012512-41-GB
EUCTR2009-012512-41-GB进行中(未招募)不适用

The pharmacokinetics of single and multiple doses of intravenous ketorolac in children - Pharmacokinetics of I.V Ketorolac in Children

HS Grampian0 个研究点开始时间: 2009年9月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children under 16 years of age administered intravenous ketorolac for routine post-operative pain relief following elective surgery, according to local treatment protocol.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients will be excluded from the study for:
  • 1: The anaesthetist does not anticipate that the child will require post surgical
  • 2: Routine evidence of liver dysfunction;
  • 3: Routine evidence of renal impairment;
  • 4: Known hypersensitivity to ketorolac or any of the components of the intravenous
  • formulation of ketorolac;
  • 5: Prior use of ketorolac within 24 hours of the study; and
  • 6: Parental or child objection to the study.

研究者

发起方
HS Grampian

相似试验

进行中(未招募)
不适用
The pharmacokinetics of single and multiple doses of intravenous paracetamol in children - Pharmacokinetics of I.V paracetamol in childreThere is no medical condition to be investigated. This is a pharmacokinetic study to be performed in children routinely treated with intravenous paracetamol for post surgical pain in line with local treatment protocol.
EUCTR2009-012585-30-GBHS Grampian Research and Development
进行中(未招募)
1 期
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects/A submitted trial is conducted on healthy subjectsMedDRA version: 21.1Level: PTClassification code: 10036312Term: Post-traumatic epilepsy Class: 100000004852MedDRA version: 22.1Level: PTClassification code: 10076982Term: Post stroke epilepsy Class: 100000004852
CTIS2023-506633-30-00Pikralida Sp. z o.o.12
进行中(未招募)
1 期
Pharmacokinetics and Safety Study of Rabeprazole Sodium in 12 to 16 Year Old Subjects
EUCTR2016-001878-15-Outside-EU/EEAEisai Medical Research Inc.24
尚未招募
2 期
Multiple-dose pharmacokinetics and ex vivo pharmacodynamics of the fixed-dosed artemisinin based combination therapies (ACTs) of the antimalarial drugs Artequick (artemisinin-piperaquine) and Coarsucam (artesunate-amodiaquine) in healthy male Vietnamese volunteers
ACTRN12609000846224Australian Department of Defence44
已完成
1 期
To know the amount of the drug and safety of Brimonidine Tartarate ophthalmic suspensio
CTRI/2019/03/018023Sun Pharma Advanced Research Company Limited13